Williams G, Lofts F, Fuessl H, Bloom S
Br Med J (Clin Res Ed). 1985 Oct 26;291(6503):1155-6. doi: 10.1136/bmj.291.6503.1155.
The association between treatment with danazol and hyperglucagonaemia was studied. Plasma glucagon concentrations were measured during an oral glucose tolerance test in seven women taking danazol and six healthy controls not taking danazol. Results showed that treatment with danazol is associated with severe hyperglucagonaemia, and in three patients glucagon concentrations reached the range suggestive of glucagonoma. It is important to recognise that this increasingly used drug may cause severe hyperglucagonaemia to prevent patients treated with danazol undergoing unnecessary investigations to localise glucagonoma.
研究了达那唑治疗与高胰高血糖素血症之间的关联。在口服葡萄糖耐量试验期间,测量了7名服用达那唑的女性和6名未服用达那唑的健康对照者的血浆胰高血糖素浓度。结果显示,达那唑治疗与严重的高胰高血糖素血症相关,在3名患者中,胰高血糖素浓度达到了提示胰高血糖素瘤的范围。认识到这种越来越常用的药物可能导致严重的高胰高血糖素血症很重要,以防止接受达那唑治疗的患者进行不必要的胰高血糖素瘤定位检查。